Kewaunee Scientific Corp(KEQU) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:10 PM ET (Korea 9/12 05:10)
Full metrics table
| Index | - | P/E | 13.19 | EPS (ttm) | 2.76 | Insider Own | 26.1% | Shs Outstand | 2.9M | Perf Week | -1.06% |
| Market Cap | 0.10B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 2.1M | Perf Month | 0.5% |
| Enterprise Value | 0.15B | PEG | - | EPS next Q | - | Inst Own | 41.81% | Short Float | 2.24% | Perf Quarter | 1.82% |
| Income | 0.01B | P/S | 0.38 | EPS this Y | - | Inst Trans | 0.7% | Short Ratio | 9.4 | Perf Half Y | 2.22% |
| Sales | 0.28B | P/B | 1.4 | EPS next 5Y | - | ROA | 4.46% | Short Interest | 0.05M | Perf YTD | -2.67% |
| Book/sh | 26.07 | P/C | 10.18 | EPS past 3/5Y | 133.18% - | ROE | 11.59% | 52W High | -24.42% ($48.17) | Perf Year | -15.48% |
| Cash/sh | 3.58 | P/FCF | 7.1 | Sales past 3/5Y | 8.71% 13.84% | ROIC | 6.86% | 52W Low | 13.78% ($32.00) | Perf 3Y | 102.5% |
| Dividend Est. | - | EV/EBITDA | 7.1 | EPS Y/Y TTM | -33.32% | Gross Margin | 28.55% | Volatility(W/M) | 4.32% 2.24% | Perf 5Y | 179.86% |
| Dividend TTM | - | EV/Sales | 0.55 | Sales Y/Y TTM | 5.33% | Oper. Margin | 5.43% | ATR (14) | 1.11 | Perf 10Y | 43.29% |
| Dividend Ex-Date | 2019/9/9 | Quick Ratio | 1.57 | EPS Q/Q | -44.44% | Profit Margin | 2.97% | RSI (14) | 48.89 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.2 | Sales Q/Q | -6.73% | SMA20 | -0.84% ($36.72) | Beta | 0.76 | Target Price | $28 |
| Payout | - | Debt/Eq | 0.74 | Earnings | 2026/9/9 | SMA50 | -0.67% ($36.66) | Rel Volume | 0.29 | Prev Close | $34.53 |
| Employees | 1231 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | - | SMA200 | -3.31% ($37.66) | Avg Volume(3M) | 0.01M | Price | $36.41 |
| IPO | 1980/3/17 | Option/Short | No/Yes | Trades | 90 | Volume | 1,449 | Change | 5.43% |
Company
KEQU is a Consumer Cyclical sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 Kewaunee Scientific is a U.S. company that designs, manufactures, and installs scientific and technical furniture and equipment for laboratories and research facilities. It supplies research infrastructure products such as steel and wood lab benches, fume hoods, storage systems, and work surfaces, and delivers them to educational, medical, and industrial research facilities both domestically and internationally from its U.S. headquarters.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
KEQU makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
The price looks about right
Trading at 13.2 times earnings.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +102.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 41.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IWC 0.00%
AVUV 0.00%
AVSC 0.00%
DFAC 0.00%
DFAS 0.00%It ranks #4 in the industry
Based on market cap of $104M.
KEQU $104M PER 13.2
SN $23B PER 32.9
SGI $15B PER 26.6
MHK $8B PER 16.8
FAQ
What kind of company is KEQU?
KEQU belongs to the Consumer Cyclical sector and operates in the Furnishings, Fixtures & Appliances industry.
What is the market cap of KEQU?
The market cap of KEQU is approximately $104M, ranking 4,536 within its sector.
What is the P/E ratio of KEQU?
KEQU has a P/E ratio of approximately 13.2x, which can be used to assess its valuation relative to the Consumer Cyclical sector average.
What is the 52-week high and low for KEQU?
KEQU has recorded a 52-week high of $48.17 and a low of $32.00.
